Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2V617F-induced myeloproliferative neoplasms
-
Published:2024-06-26
Issue:1
Volume:14
Page:
-
ISSN:2044-5385
-
Container-title:Blood Cancer Journal
-
language:en
-
Short-container-title:Blood Cancer J.
Author:
Hu Mengshi,
Yang Tao,
Yang Linyu,
Niu Lu,
Zhu Jinbing,
Zhao Ailin,
Shi Mingsong,
Yuan Xue,
Tang Minghai,
Yang Jianhong,
Pei Heying,
Yang Zhuang,
Chen QiangORCID,
Ye Haoyu,
Niu TingORCID,
Chen LijuanORCID
Publisher
Springer Science and Business Media LLC